Dr Ludo van der Pol - MMN Innovation and Trials

What has enabled recent developments in understanding of the mechanisms that cause MMN?

Why have these developments been important in the development of new possible treatments currently being trialled?

What’s involved in clinical trials and what do possible participants need to think about when considering getting involved?

What are some of the challenges of getting drugs to market once they have been successfully trialled? 

Just some of the questions addressed in the latest episode of our podcast with Dr Ludo van der Pol, Professor of Neurology, Utrecht Medical Centre.

At a time when two companies (Dianthus and Argenx) are looking for patients to participants in trials of possible MMN treatments. This episode is one to listen to if you want to understand the drug trial process better.

For more information on these active trials go to https://clinicaltrials.gov/ and search for #MultifocalMotorNeuropathy